Researchers Point To MedTech Overuse Amid Reform Debate
This article was originally published in The Gray Sheet
Executive Summary
Several academic research teams highlighted cases of overuse of medical technologies last week, just as the device industry is stepping up efforts to remove itself from the crosshairs of policymakers looking to cut spending and raise revenues as part of health care reform
You may also be interested in...
Analysis Questions Value Of Robotic Prostate Surgery
Minimally invasive removal of the prostate has some advantages, but it does not measure up to traditional open surgery in preventing incontinence and erectile dysfunction, Harvard researchers reported in the Journal of the American Medical Association Oct. 14
Finance Dems Block Move To Strip Device Fee, But Signal Room To Negotiate
An amendment that would have stripped a proposed $4 billion annual fee on device manufacturers from health care reform legislation was voted down by Senate Finance Committee Democrats Oct. 1, but they signaled an interest to negotiate further
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.